Literature DB >> 26561294

Enrollment volume effect on risk factor control and outcomes in the SAMMPRIS trial.

David Chiu1, Richard P Klucznik2, Tanya N Turan2, Michael J Lynn2, Charles D McCane2, Lawrence B Katz2, Azhar Nizam2, Colin P Derdeyn2, David Fiorella2, Bethany F Lane2, Jean Montgomery2, Scott Janis2, Marc I Chimowitz2.   

Abstract

OBJECTIVE: The role of physician experience and patient volumes on the outcome of surgical or endovascular procedures has been well-studied but there are limited data on how these factors affect the outcome of medical therapy.
METHODS: In the stenting and medical cohorts of the Stenting and Aggressive Medical Management for the Prevention of Recurrent Ischemic Stroke (SAMMPRIS) trial, we compared Kaplan-Meier (K-M) curves for the primary endpoint (any stroke or death within 30 days of enrollment or ischemic stroke in the territory beyond 30 days) using the log-rank test and the percentages of patients achieving target levels for primary and secondary risk factors during the study using Fisher exact test between patients at high-enrolling (≥12 patients) vs low-enrolling (<12 patients) sites.
RESULTS: In the stenting group, the K-M curves for the primary endpoint were similar at high-enrolling sites and low-enrolling sites (p = 0.93) with rates of 13.5% vs 14.7% at 30 days and 19.0% vs 20.6% at 2 years. In the medical group, the K-M curves differed between high-enrolling sites and low-enrolling sites (p = 0.0005) with rates of 1.8% vs 9.8% at 30 days and 7.3% vs 20.9% at 2 years. The percentages of patients who achieved targets for low-density lipoprotein cholesterol and systolic blood pressure at high- vs low-enrolling sites in both treatment groups combined were 64% vs 49% (p = 0.003) and 70% vs 59% (p = 0.026), respectively.
CONCLUSIONS: High-enrolling sites in SAMMPRIS achieved better control of primary risk factors and much lower rates of the primary endpoint than low-enrolling sites in the medical group, suggesting that experience with medical management is an important determinant of patient outcome.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Year:  2015        PMID: 26561294      PMCID: PMC4691681          DOI: 10.1212/WNL.0000000000002191

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Operator experience and carotid stenting outcomes in Medicare beneficiaries.

Authors:  Brahmajee K Nallamothu; Hitinder S Gurm; Henry H Ting; Philip P Goodney; Mary A M Rogers; Jeptha P Curtis; Justin B Dimick; Eric R Bates; Harlan M Krumholz; John D Birkmeyer
Journal:  JAMA       Date:  2011-09-28       Impact factor: 56.272

2.  Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial.

Authors:  Marc I Chimowitz; Michael J Lynn; Tanya N Turan; David Fiorella; Bethany F Lane; Scott Janis; Colin P Derdeyn
Journal:  J Stroke Cerebrovasc Dis       Date:  2011 Jul-Aug       Impact factor: 2.136

3.  Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial.

Authors:  Colin P Derdeyn; David Fiorella; Michael J Lynn; Stanley L Barnwell; Osama O Zaidat; Philip M Meyers; Y Pierre Gobin; Jacques Dion; Bethany F Lane; Tanya N Turan; L Scott Janis; Marc I Chimowitz
Journal:  J Neurointerv Surg       Date:  2012-09-12       Impact factor: 5.836

4.  Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.

Authors:  Tanya N Turan; Michael J Lynn; Azhar Nizam; Bethany Lane; Brent M Egan; Ngoc-Anh Le; Maria F Lopes-Virella; Kathie L Hermayer; Oscar Benavente; Carole L White; W Virgil Brown; Michelle F Caskey; Meghan R Steiner; Nicole Vilardo; Andrew Stufflebean; Colin P Derdeyn; David Fiorella; Scott Janis; Marc I Chimowitz
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-09-01

5.  Stenting versus aggressive medical therapy for intracranial arterial stenosis.

Authors:  Marc I Chimowitz; Michael J Lynn; Colin P Derdeyn; Tanya N Turan; David Fiorella; Bethany F Lane; L Scott Janis; Helmi L Lutsep; Stanley L Barnwell; Michael F Waters; Brian L Hoh; J Maurice Hourihane; Elad I Levy; Andrei V Alexandrov; Mark R Harrigan; David Chiu; Richard P Klucznik; Joni M Clark; Cameron G McDougall; Mark D Johnson; G Lee Pride; Michel T Torbey; Osama O Zaidat; Zoran Rumboldt; Harry J Cloft
Journal:  N Engl J Med       Date:  2011-09-07       Impact factor: 91.245

6.  Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS).

Authors:  David Fiorella; Colin P Derdeyn; Michael J Lynn; Stanley L Barnwell; Brian L Hoh; Elad I Levy; Mark R Harrigan; Richard P Klucznik; Cameron G McDougall; G Lee Pride; Osama O Zaidat; Helmi L Lutsep; Michael F Waters; J Maurice Hourihane; Andrei V Alexandrov; David Chiu; Joni M Clark; Mark D Johnson; Michel T Torbey; Zoran Rumboldt; Harry J Cloft; Tanya N Turan; Bethany F Lane; L Scott Janis; Marc I Chimowitz
Journal:  Stroke       Date:  2012-09-13       Impact factor: 7.914

7.  Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.

Authors:  Colin P Derdeyn; Marc I Chimowitz; Michael J Lynn; David Fiorella; Tanya N Turan; L Scott Janis; Jean Montgomery; Azhar Nizam; Bethany F Lane; Helmi L Lutsep; Stanley L Barnwell; Michael F Waters; Brian L Hoh; J Maurice Hourihane; Elad I Levy; Andrei V Alexandrov; Mark R Harrigan; David Chiu; Richard P Klucznik; Joni M Clark; Cameron G McDougall; Mark D Johnson; G Lee Pride; John R Lynch; Osama O Zaidat; Zoran Rumboldt; Harry J Cloft
Journal:  Lancet       Date:  2013-10-26       Impact factor: 79.321

8.  A cluster randomized trial to assess the effect of clinical pathways for patients with stroke: results of the clinical pathways for effective and appropriate care study.

Authors:  Massimiliano Panella; Sara Marchisio; Romeo Brambilla; Kris Vanhaecht; Francesco Di Stanislao
Journal:  BMC Med       Date:  2012-07-10       Impact factor: 8.775

9.  Carotid stenting: is there an operator effect? A pooled analysis from the carotid stenting trialists' collaboration.

Authors:  David Calvet; Jean-Louis Mas; Ale Algra; Jean-Pierre Becquemin; Leo H Bonati; Joanna Dobson; Gustav Fraedrich; Olav Jansen; Willem P Mali; Peter A Ringleb; Gilles Chatellier; Martin M Brown; D Calvet; J L Mas; A Algra; J P Becquemin; L H Bonati; J Dobson; G Fraedrich; O Jansen; W P Mali; P A Ringleb; G Chatellier; M M Brown; A Algra; J P Becquemin; G Chatellier; J L Mas; G Fraedrich; P A Ringleb; O Jansen; M M Brown
Journal:  Stroke       Date:  2013-12-17       Impact factor: 7.914

  9 in total
  2 in total

Review 1.  Management of Symptomatic Intracranial Stenosis.

Authors:  David A Hoak; Helmi L Lutsep
Journal:  Curr Cardiol Rep       Date:  2016-09       Impact factor: 2.931

2.  Safety of endovascular therapy for symptomatic intracranial artery stenosis: a national prospective registry.

Authors:  Yabing Wang; Tao Wang; Adam Andrew Dmytriw; Kun Yang; Liqun Jiao; Huaizhang Shi; Jie Lu; Tianxiao Li; Yujie Huang; Zhenwei Zhao; Wei Wu; Jieqing Wan; Qinjian Sun; Bo Hong; Yongli Li; Liyong Zhang; Jianfeng Chu; Qiong Cheng; Yiling Cai; Pengfei Wang; Qi Luo; Hua Yang; Baijing Dong; Yang Zhang; Jun Zhao; Zuoquan Chen; Wei Li; Xiaoxin Bai; Weiwen He; Xueli Cai; Maimai Ti; Osama O Zaidat
Journal:  Stroke Vasc Neurol       Date:  2021-10-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.